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Abstract
During the COVID-19 pandemic, HIV clinics had to transform care delivery for people with HIV (PWH). We developed a
multifaceted telehealth implementation strategy and monitored number of out of care patients (OOC), medical visit frequency
(MVF), gap in care (GiC) and viral suppression (VS), and compared measures to baseline data. Between April and October 2020,
1559 visits were scheduled; 328 (21%) were missed, and 63 (4%) were new to care. Of the remaining 1168 follow-up visits,
412 (35%) were telehealth visits. As of October 2020, there were 53 patients OOC, MVF was 55% and GiC was 24% compared
to 34, 69% and 14% at baseline, respectively. Overall VS rate remained high at 93% (97% for telehealth and 91% for in-person visits,
p ¼ 0.0001). Our implementation strategy facilitated quick provision of telehealth to a third of PWH receiving care in our clinic.
While MVF decreased and GiC increased, VS rates remained high.
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Background
COVID-19 was declared a pandemic 1 year after the United
States administration announced its “End the HIV Epidemic:
A Plan for America” (EHE) initiative, with the goal of 75%
reduction in new HIV infections by 2025 and at least 90%
reduction by 2030.1 One of the key strategies of the EHE
initiative is to treat people with HIV (PWH) rapidly and effec-
tively to reach viral suppression (VS). PWH who achieve sus-
tained VS have improved health outcomes and do not transmit
the disease to their sexual partners.2,3 In addition, in one study,
PWH with sustained VS had similar risk of COVID-19 severity
and complications compared to those without HIV.4 Retention
in care (RiC) and antiretroviral therapy (ART) adherence are
key factors in achieving sustained VS.5 Therefore, it is impera-
tive for HIV clinics to implement strategies to ensure RiC for
PWH, particularly during the COVID-19 pandemic.
The University of Nebraska Medical Center Specialty Care
Center (UNMC SCC) is the largest provider of comprehensive
HIV care in Nebraska. The clinic provides primary and
HIV-focusedmedical services as well as a wide range of support
services. Over the past 3 years, the SCC patients maintained a
viral load suppression rate of 90% or greater, which exceeds the
target set forth by the National HIV Strategy 2020 and the Joint
United Nations Program on HIV/AIDS.6 The objectives of this
quality improvement project were to ensure successful imple-
mentation of telehealth services for PWH,whilemaintaining the
clinic’s high VS rate during the COVID-19 pandemic.
Methods
Clinic Operation Implementation Strategy
We developed a multifaceted implementation strategy for SCC
operation. In March 2020we recognized the need to adjust SCC
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operations to promote patient and staff safety during the pan-
demic by limiting in-person interactions. This conflicted with
our usual approach to RiC, which relied on frequent patient
visits to the clinic not only for clinical care, but also for
ongoing medication adherence and case management support.
As we recognized the need to transform SCC operations
during the pandemic, our larger university healthcare system
was rapidly developing policies and infrastructure to promote
the transition to telehealth (defined as 2 way communication
between patient and provider via either audio or video). The
telehealth implementation strategy for the HIV clinic included:
1) assessment for readiness and identification of barriers and
facilitators, 2) identification and preparation of telehealth
champions, 3) organization of clinician implementation meet-
ings, and 4) conduct of all necessary staff training.
We identified several barriers including patient access to
technology, staff unfamiliarity with telehealth documentation,
and wide variations in providers’ criteria for who can receive a
visit using telehealth. As a result, we developed an implemen-
tation blueprint that incorporated resolutions to these barriers.
To address the first barrier of patient access to technology,
we opted to utilize telephone visits as the preferred telehealth
modality. While many patients did not have access to
video-enabled devices, they were able to participate in a tele-
phone visit. We built templates in the electronic health record
(EHR) and educated staff on how to change an in-person visit
to telephone visit. We informed patients of the option to transi-
tion to telephone visits through outreach by clinic staff or when
patients called to cancel their appointments due to concern of
exposure to COVID-19.
Our immediate focus shifted to defining patient eligibility
criteria for telephone visits. Clinic champions used decision
trees to develop simple algorithms for new and established
patients. These decision trees were based on date of most recent
office visit, stability of HIV disease, most recent viral load and
CD4 count, and ART refill histories as proxy of medication
adherence. The algorithms incorporated referral to case
management services, vaccination, and laboratory visits.
Once telephone visit eligibility criteria were formalized, we
recognized the need for consistent and efficient EHR tools to
document HIV management, capture criteria for billing, and
incorporate prompts for COVID-19 screening, testing, and edu-
cation. Clinic champions developed a Plan Do Study Act
(PDSA) cycle to create and disseminate a progress note tem-
plate for telephone visits that incorporated elements necessary
for HIV care, billing and coding.
Clinician implementation meetings equipped providers with
updated algorithms and progress note template. HIV clinic staff
participated in trainings on telehealth, rescheduling of patients,
proper use of personal protective equipment, SARS-CoV-2
swab collection, and physical distancing to safely accommo-
date patients who did not meet criteria for telehealth.
Outcome Measures
We conducted a retrospective chart review to collect patient
demographic information and outcomes of telehealth imple-
mentation for established patients who had a follow up visit
between April and October 2020. Our primary outcome was
VS defined as the percentage of patients with a most recent HIV
RNA of < 200 copies per mL. Our secondary outcomes included
number of patients who were out of care (OOC) defined as
patients whose most recent office visit was >12 months prior,
and RiC as measured bymedical visit frequency (MVF) defined
by Health Resources and Services Administration HIV and
AIDS Bureau (HRSA HAB) as percentage of patients who had
one visit in each 6 months of the preceding 24 months with at
least 60 days between visits; and gap in care (GiC) defined as the
percentage of patients who had no visit in the preceding
6 months. We selected these RiC measures based on HAB core
measures.7 These outcomes were compared to pre-pandemic
baseline outcomes as of February, 2020. Descriptive statistics
were used to summarize the data. A chi square test was used to
compare viral suppression rate in patients who received tele-
phone visits to those who received in person visits.
Ethical Approval and Informed Consent
The study was deemed exempt under the 45 CFR 46:104 (d),
category 4 by the UNMC Institutional Review Board (IRB #
681-20-EX)
Results
A total of 1559 visits were scheduled between April 1 and
October 30, 2020; 328 (21%) were missed, and 63 (4%) were
What Do We Already Know about This Topic?
The COVID-19 pandemic has drastically altered the
healthcare delivery system for clinics providing HIV care
with many clinics transitioning rapidly to alternative
methods such as telehealth.
How Does Your Research Contribute
to the Field?
Our quality management project demonstrates the ben-
efit of screening patients for telehealth eligibility, and
showed that these interventions can lead to maintenance
of viral suppression rates despite decreases in visit
frequency.
What Are Your Research’s Implications toward
Theory, Practice, or Policy?
Telehealth is an effective modality for HIV care during
health emergencies and should be incorporated into
routine care delivery along with guidelines on implemen-
tation and outcome measures.
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new patient visits, which were excluded from the analysis. Of
the remaining 1167 established patient visits, 412 (35%) were
telephone visits. Table 1 outlines the demographic characteris-
tics of established patients who received in-person visits com-
pared to those who received telephone visits. There were no
differences in age, gender, race, or ethnicity between the 2
groups. The majority of patients had stable permanent housing
(95% for both telephone and in-person visits) and 33% of
patients lived at or below 100% of the federal poverty level
(31% for telephone and 33% for in person visit). Median CD4
count (Min-Max) was 592 (24-2374) cell/mcL; [568 (24-2368)
cell/mcL for telephone and 569 (24-2368) cell/mcL for
in-person visits]. Overall VS rate remained high at 93% with
higher VS rates in PWH who received telephone: 97% (1087/
1165) vs. those who received in-person visit 91% (688/754);
p value ¼ 0.0001.
By the end of October 2020, there were a total of 53 patients
OOC compared to 34 patients at pre-pandemic baseline. Our
MVF decreased to 55% (492/899) compared to 69%, and our
GiC increased to 24% (217/911) compared to 14% at
pre-pandemic baseline.
Discussion
We successfully provided telehealth services in the form of
telephone visits to 35% of PWH receiving care at UNMC SCC
during the first 7 months of the COVID-19 pandemic. Our
paper details the steps we took to transition PWH from
in-person visits to telehealth using a comprehensive implemen-
tation strategy taking into account patient, staff, and system
level barriers. We identified champions to lead the change and
used quality management tools to address these barriers. We
regularly updated staff on changes to the telehealth algorithms.
Our implementation strategy ensured quick adoption of
telehealth while maintaining a high VS rate of 93%, with
patients receiving telehealth having higher VS rate than those
receiving in-person visits. Although these findings are prelim-
inary, they suggest that telehealth is a reliable strategy, which
provides continuity of care for PWH while minimizing the risk
of exposure to COVID-19 during travel to and at the clinic.
Our findings are in contrast to a recent study from San
Francisco, which showed lower VS rates during the pandemic
despite higher attendance to telemedicine visits.8 A survey
examining the acceptability of telemedicine in PWH prior to
Table 1. Demographic and Clinical Characteristics of Patients Who Received Telemedicine vs. in-Person Visits.
In person visit (N ¼ 755) Telemedicine visit (N ¼ 412) All follow ups (N ¼ 1,167)
Age (Years)
Median [Min, Max] 47[19,84] 51[21,77] 48[19,84]
Gender
Female 182 (24.1%) 94 (22.8%) 276 (23.7%)
Male 565 (74.8%) 313 (76%) 878 (75.2%)
Transgender 8 (1.1%) 5 (1.2%) 13 (1.1%)
Race
Asian 28 (3.7%) 8 (1.9%) 36 (3.9%)
Black or African American 235 (31.1%) 116 (28.2%) 351 (30.1%)
Other races 35 (3.4%) 10 (2.5%) 45 (3.9%)
White or Caucasian 457 (60.5%) 278 (67.5%) 735 (63%)
Ethnicity
Hispanic or Latino 125 (16.5%) 63 (15.3%) 188 (16.1%)
Not Hispanic or Latino 629 (83.3%) 348 (84.5%) 977 (83.7%)
Percent federal poverty level
<100% 251 (33.2%) 129 (31.3%) 380 (32.6%)
100-200% 184 (24.4%) 83 (20.1%) 267 (22.9%)
201-300% 133 (17.6%) 81 (19.7%) 214 (18.3%)
301-400% 58 (7.7%) 35 (8.5%) 93 (8%)
>400% 28 (3.7%) 11 (2.7%) 39 (3.3%)
Missing 101 (13.4%) 73 (17.7%) 174 (15%)
Housing status
Incarcerated 1 (0.1%) 2 (0.5%) 3 (0.3%)
Non-permanent housing 38 (5%) 19 (4.6%) 57 (4.9%)
Stable/permanent 714 (94.6%) 391 (95%) 1105 (94.7%)
Viral suppression (HIV RNA < 200 copies/mL)
No 66 (8.7%) 12 (2.9%) 78 (6.7%)
Yes 688 (91.1%) 399 (96.8%) 1087 (93.1%)
Last CD4 cell count (cells/mm3)
Mean (SD) 619.4 (345.3) 679 (347.1) 639.4 (346.8)
Median [Min, Max] 568.5[24-2368] 629.5[84-2374] 591.5[24-2374]
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the COVID-19 pandemic found that 57% of patients chose
telemedicine as their preferred modality of HIV care.9 Reasons
cited by participants included ability to fit better with their
schedule, decreased travel time and privacy. Telemedicine was
the modality of choice for primarily U.S. born, urban, educated
men who have sex with men.
One of the challenges in delivering telehealth to PWH is
ensuring equitable access to care as not all patients have access
to technology. Our larger health system placed an emphasis on
synchronous video visits for the telehealth transition. We
audited SCC patients’ access to technology using a surrogate
of enrollment in the EHR patient portal, which was required to
support a secure video visit with a clinician. We found that 50%
of the SCC patients were not enrolled in the patient portal. For
some patients this was due to privacy concerns, but most
patients did not have consistent access to a cell phone, internet
or data service. Due to the urgency of telehealth implementa-
tion]and to ensure equitable access to care, we decided to
forego video visits and proceeded with telephone visits instead.
We educated providers on documentation and billing require-
ments for this new mode of patient care and found quick uptake
by both patients and providers.
Concurrent with the SCC telehealth implementation plan,
the U.S. Department of Health and Human Services Guidelines
Panel released Interim Guidance for COVID-19 and PWH,
which highlighted: 1) the importance of PWH continuing unin-
terrupted ART during the pandemic, 2) the risk/benefit consid-
eration for patients attending in-person appointments, 3) use of
telephone or virtual visits for routine and non-urgent care, and
4) acceptability of postponing routine medical and laboratory
visits for PWH with suppressed viral load.10 Our historically
high rate of VS at the SCC further supported the adoption of
telehealth to provide ongoing care to PWH.
Interestingly, the increase in GiC and decrease in MVF did
not affect our VS rate. These changes in RiC measures could
partially be due to the fact that many patients canceled their
appointments in March and early April due to concern of con-
tracting COVID-19 in the healthcare setting. In addition, we
provided adequate refills to patients beyond the routine
6-month supply that we normally provide, which enabled
patients to delay their clinic visits. While MVF and GiC are
the measures utilized by HAB to track RiC, they may not be
applicable during the pandemic. We utilized other measures of
adherence such as refill history to qualify patients for telephone
visits.11
Our study has several limitations including the fact this
project was conducted at a single academic center therefore;
the results might not be applicable to other patient populations.
While telehealth was associated with higher VS rate than
in-person visits, we can not assume a causative relationship
as patients who received telehealth were pre-selected based
on their prior viral suppression. In addition, due to the retro-
spective nature of data collection we were unable to capture
other variables that might have contributed to the success of
implementation of telehealth in this population such as patient
education and employment status. Nonetheless, our findings
provide preliminary evidence that telehealth is a feasible alter-
native to in-person visits for PWH during the COVID-19 pan-
demic and it has no adverse effects on patient outcomes.
Conclusion
The COVID-19 pandemic has impacted many aspects of care
delivery for PWH. Supported by the Interim Guidance for
COVID-19 and PWH, the SCC quickly implemented a tele-
health strategy to continue providing care to PWH, specifically
those patients with evidence of ART adherence and HIV dis-
ease control. Our data suggests that when these qualification
measures are enforced, VS can be maintained during a public
health emergency.
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